Back to search

Article

Biosynthesis of cannabinoid precursor olivetolic acid by overcoming rate-limiting steps in genetically engineered <i>Yarrowia lipolytica</i>

2021-06-10

Abstract excerpt

Natural products acting on our central nervous systems are in utmost demand to fight against pain and mental disorders. Cannabinoids (CBDs) are proven neuroactive agents to treat anxiety, depression, chronic pain diseases, seizure, strokes and neurological disorders. The scarcity of the hemp-sourced CBD products and the prohibitive manufacturing cost limit the wide application of CBDs. Yeast metabolic engineering...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fd06f338-d763-592d-9707-ce3647034a8d
DOI
10.1101/2021.06.10.447928
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Biosynthesis of cannabinoid precursor olivetolic acid by overcoming rate-limiting steps in genetically engineered <i>Yarrowia lipolytica</i>DOI 10.1101/2021.06.10.447928
Select a neighboring publication to make it the new centre.